IL-7R-alpha specific antibodies for treating acute lymphoblastic leukemia

Anti-MET antibodies and uses thereof

Humanized and affinity matured antibodies to FcRH5 and methods of use

Anti-Interleukin-6 receptor antibodies

Method of treating cancer by administering an antibody that binds transforming growth factor beta (TGF-beta) 1, TGF-beta 2 and TGF-beta 3

Antibodies recognizing α-synuclein

Multivalent and multispecific DR5-binding fusion proteins and methods of treating neoplasms

PD-1 antibody, antigen-binding fragment thereof, and medical application thereof

Immunoglobulin single variable domains directed against macrophage migration inhibitory factor

TREATMENT WITH ANTI-VEGF ANTIBODIES

ANTIBODIES AGAINST HUMAN CSF-1R AND USES THEREOF

Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors

Internalizing moieties

Binding molecules specific for CD73 and uses thereof

Bispecific CXCR4-CD4 polypeptides with potent anti-HIV activity

Antibodies and antigen-binding fragments that specifically bind to microtubule-associated protein tau

Amyloid beta oligomer specific binding molecule

Humanized anti-tau antibodies and compositions for and methods of making and using in treatment, diagnosis and monitoring of tauopathies

B-CELL REDUCTION USING CD37-SPECIFIC AND CD20-SPECIFIC BINDING MOLECULES

Humanized antibodies with increased stability

Immunogenetic restriction on elicitation of antibodies

Method for mass humanization of non-human antibodies

ANTI-ALPHA-V INTEGRIN ANTIBODY FOR THE TREATMENT OF PROSTATE CANCER

CD3 binding antibodies

Immunoglobulins and uses thereof

Restricted immunoglobulin heavy chain mice

BINDING MEMBERS WITH ALTERED DIVERSITY SCAFFOLD DOMAINS

Antibody specifically binding to IL-17A, encoding nucleic acid, and method of using the antibody

Antibody specifically binding to an isolated peptide derived from vimentin or a fragment binding to the peptide

Middle east respiratory syndrome coronavirus immunogens, antibodies, and their use

Engineered Rabbit Antibody Variable Domains And Uses Thereof

Use of myostatin inhibitors and combination therapies

Heavy chain only antibodies to ANG-2

Anti-CD19 antibodies with reduced immunogenicity

Antibodies with low immunogenicity and uses thereof

Humanized antibodies transmigrating the blood-brain barrier and uses thereof

Method of discovering specific functional antibodies

Single-domain antibodies and variants thereof against CTLA-4

LAG-3 antibody, antigen-binding fragment thereof, and pharmaceutical application thereof

Rationally designed, synthetic antibody libraries and uses therefor

TRANSGENIC NON-HUMAN ANIMALS PRODUCING MODIFIED HEAVY CHAIN-ONLY ANTIBODIES

Multispecific antibody molecules comprising lambda and kappa light chains

Methods of cancer treatment and therapy using a combination of antibodies that bind glycosylated PD-L1

Methods for producing Fabs and bi-specific antibodies

Amino acid sequences that modulate the interaction between cells of the immune system

Anti-CGRP compositions and use thereof

Human immunodeficiency virus neutralizing antibodies

Rationally designed, synthetic antibody libraries and uses therefor

Cys80 conjugated immunoglobulins

Single domain binding molecule

Variant antibodies that bind AIP2

HUMANIZED ANTI-FACTOR D ANTIBODIES AND USES THEREOF

CD47 antibodies and uses thereof for treating cancer

Filovirus antibody

Host cell comprising nucleic acids encoding bispecific antibodies binding to beta-klotho and fibroblast growth factor receptor 1 and antibody production

Anti-Axl antagonistic antibodies

Anti-C10ORF54 antibodies and uses thereof

Antibodies to TGF-β

Method for treating IL-8-related diseases

Solubility optimization of immunobinders

ANGPTL8-binding agents and methods of use thereof

Humanized tau antibodies in alzheimer's disease

EPITOPES OF EPIDERMAL GROWTH FACTOR RECEPTOR SURFACE ANTIGEN AND USE THEREOF

CD39 VASCULAR ISOFORM TARGETING AGENTS

Heterodimeric immunoglobulins

Humanized antibodies that recognize alpha-synuclein

Antibody molecules to dengue virus and uses thereof

T cell receptor-like antibodies specific for a WTI peptide presented by HLA-A2

Monovalent anti-huTNFR1 antibodies, encoding nucleic acids thereof and methods of treatment thereof

Chimeric antigen receptors targeting epidermal growth factor receptor variant III

Anti-Notch3 antibody

Binding domain or antibody specific to a human serum albumin (HSA)

Immunoglobulins directed to bacterial, viral and endogenous polypetides

Ig-pCONSENSUS GENE VACCINATION PROTECTS FROM ANTIBODY-DEPENDENT IMMUNE PATHOLOGY IN AUTOIMMUNE DISEASE

Transgenic animal for production of antibodies having minimal CDRs

Bispecific antibodies for use in stem cell transplantation

Anti-jagged antibodies and methods of use

Anti-CTLA-4 antibodies and methods of use thereof

ANG2-BINDING MOLECULES

Pharmaceutical compositions comprising a polypeptide that binds to IL-6

ANTI-TIGIT ANTIBODIES AND METHODS OF USE

Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying same

Antibody frameworks

T cell recruiting polypeptides based on TCR alpha/beta reactivity

HUMANIZED AND CHIMERIC MONOCLONAL ANTIBODIES TO CD47

Methods of treating by administering anti-kit antibodies

Anti-CD38 antibodies and methods of use

Antibody polypeptides that antagonize CD40L

Humanized anti-claudin-1 antibodies and uses thereof

Optimized variants of anti-vegf antibodies and methods of use thereof in treatment

Polypeptides

Anti-interleukin-33 antibodies and uses thereof

Anti-CGRP compositions and use thereof

Antagonist Antibodies Directed Against Calcitonin Gene-Related Peptide and Methods Using Same

COMMON LIGHT CHAIN MOUSE

IMMUNOGLOBULIN VARIANTS WITH ALTERED BINDING TO PROTEIN A

ANTI-IL-6 RECEPTOR ANTIBODY

Mice expressing a limited immunoglobulin light chain repertoire

Anti-human PD-L1 humanized monoclonal antibody and application thereof

Neutralizing antibodies to HIV-1 GP41 and their use

Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases

METHODS FOR MAKING FULLY HUMAN BISPECIFIC ANTIBODIES USING A COMMON LIGHT CHAIN

ANTI-CD39 ANTIBODIES

IMMUNOGLOBULIN VARIANTS AND USES THEREOF

Anti-human 4-1BB antibodies and uses thereof

Antibodies against human CSF-1R and uses thereof

Anti-human PD-1 humanized monoclonal antibody and application thereof

Anti-transthyretin antibodies

Neutralizing antibodies to Ebola virus glycoprotein and their use

Antibodies against CD73 and uses thereof

ST2L antagonists and methods of use

Anti-B7-H4 antibodies and immunoconjugates

Antibodies recognizing alpha-synuclein

POLYPEPTIDE MODIFICATION METHOD FOR PURIFYING POLYPEPTIDE MULTIMERS

PcrV binding single variable domain antibodies

ANTIBODIES AGAINST CD73 AND USES THEREOF

Anti-tenascin C antibodies and uses thereof

POLYPEPTIDES, ANTIBODY VARIABLE DOMAINS & ANTAGONISTS

Frizzled5 protein-binding agents

Binding molecules specific for HER3 and uses thereof

Anti P2Xreceptor antibodies and fragments thereof

Common light chain mouse

Method for producing antibody

INTERCALATED SINGLE-CHAIN VARIABLE FRAGMENTS

Methods of engineering surface charge for bispecific antibody production

Antibody against EGFRvIII and use thereof

Method of treatment with humanized anti-IL-18 antibodies

Polynucleotides encoding optimized variants of anti-VEGF antibodies

Single domain serum albumin binding protein

Combination Therapies Employing GITR Binding Molecules

Biological materials related to HER3

Anti-PD-L1 nanobody and use thereof

ANTIBODIES TO HUMAN GDF8

COMMON LIGHT CHAIN MOUSE

Self-crosslinking antibodies

CXCR2 antibodies and uses thereof

ANTI-PD-L1 ANTIBODIES, COMPOSITIONS AND ARTICLES OF MANUFACTURE

Antibodies to surface determinants

Broadly neutralizing HIV-1 antibodies that bind to the CD4-binding site of the envelope protein

Antibodies for treatment of cancer expressing claudin 6

Binding agents

ANTI-LRP5 ANTIBODIES AND METHODS OF USE

METHODS OF MODIFYING ANTIBODIES, AND MODIFIED ANTIBODIES WITH IMPROVED FUNCTIONAL PROPERTIES

Anti-myostatin antibodies and methods of use

HA binding agents

Antibody capable of binding to norovirus, composite, detection device and method using the same

Antibody libraries

Monoclonal antibodies for use in diagnosis and therapy of cancers and autoimmune disease

Deimmunized Serum-Binding Domains and Their Use in Extending Serum Half-Life

Multispecific antibodies that target HIV GP120 and CD3

Stable and soluble antibodies inhibiting TNFα

Anti-activin A antibodies and uses thereof

Therapeutic DLL4 Binding Proteins

Anti-laminin4 antibodies specific for LG4-5

ANTI-BLOOD DENDRITIC CELL ANTIGEN 2 ANTIBODIES AND USES THEREOF

PYRROLOBENZODIAZEPINES AND ANTIBODY DISULFIDE CONJUGATES THEREOF

TREATMENT AND PROPHYLAXIS OF AMYLOIDOSIS

Production of T cell retargeting hetero-dimeric immunoglobulins

Compositions and methods for diagnosis and treatment of hepatic cancers

Polypeptides inhibiting CD40L

TECHNIQUES FOR PREDICTING, DETECTING AND REDUCING ASPECIFIC PROTEIN INTERFERENCE IN ASSAYS INVOLVING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS

Anti-PD-L1 antibodies and uses thereof

NOVEL BISPECIFIC ANTIGEN BINDING MOLECULES CAPABLE OF SPECIFIC BINDING TO CD40 AND TO FAP

Biopharmaceutical compositions and related methods

Transgenic animal for production of antibodies having minimal CDRS

PD-L1 antibody, antigen-binding fragment thereof and medical application thereof

Glycan-interacting compounds and methods of use

Immunomodulatory antibodies

BINDING MEMBERS OF INTERLEUKIN-4 RECEPTOR ALPHA (IL4-Ra)

P2X7 receptor binders and polypeptides comprising the same

Pyrrolobenzodiazepine antibody drug conjugates and methods of use

Epitope of optimized humanized monoclonal antibodies against activated protein C and uses thereof

Anti-CGRP/anti-IL-23 bispecific antibodies and uses thereof

Method for mass humanization of rabbit antibodies

Antibodies specific for IL-21 and uses thereof

Anti-TNFRSF25 antibodies

Human TNFRSF25 antibody

Serum albumin-binding immunoglobulin variable domains

Methods for producing fabs and bi-specific antibodies

Combination therapy for the treatment of cancer

Methods for treating ocular diseases with brolucizumab

GRAM-POSITIVE BACTERIA SPECIFIC BINDING COMPOUNDS

Antibodies against kidney associated antigen 1 and antigen binding fragments thereof

Neutralizing antibodies to Ebola virus glycoprotein and their use

FORMULATIONS COMPRISING PD-1 BINDING PROTEINS AND METHODS OF MAKING THEREOF

ANTI-ErbB2 ANTIBODIES

Antigen-binding constructs targeting HER2

Antibody polypeptides and uses thereof

CD3 binding polypeptides

HUMANIZED ANTI-CD19 ANTIBODIES AND THEIR USE IN TREATMENT OF ONCOLOGY, TRANSPLANTATION AND AUTOIMMUNE DISEASE

Antibody molecules which bind CD22

Humanized or affinity-matured anti ang-2 antibody and uses thereof

Anti-C5a antibodies

DNA molecules encoding antibodies to tau and methods of making thereof

Anti-PHF-tau antibodies and uses thereof

Humanized anti-TF-antigen antibodies

Method of treating IgA nephropathy by administering humanized APRIL-binding antibodies

Antibody that binds to human programmed death ligand 2 (PD-L2) and uses thereof

COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR

Antibody Fragments Against the Insulin Receptor and Uses Thereof to Treat Hypoglycemia

IL-7R-alpha specific antibodies for treating acute lymphoblastic leukemia

Anti-PD1 antibodies and their use as therapeutics and diagnostics

Treating inflammation with IL-17/IL-23 bispecific antibodies

NOVEL ANTI-IL13 ANTIBODIES AND USES THEREOF

CD47 antibodies, methods, and uses

Cytotoxicity-inducing therapeutic agent

Non-human animals that select for light chain variable regions that bind antigen

Antibodies against human CSF-1R and uses thereof

Antibody to human and mouse Sema3A and use thereof

Antibody to human and mouse SEMA3A and use thereof

Middle east respiratory syndrome coronavirus immunogens, antibodies, and their use

Antibodies against LIF and uses thereof

Humanized anti-CCR7 receptor antibodies

Single chain antibody domains for detection of anti-botulinum neurotoxin domains and methods of their use

Bispecific HIV-1-neutralizing antibodies

Anti-tryptase antibodies, compositions thereof, and uses thereof

Methods and compositions for treating and preventing disease associated with alpha-v beta-8 integrin

HIV-1 GP120 CD4 binding site antibodies targeting HIV escape mutants

Immunologically active polypeptide

MUC1* antibodies

Antibody variants

Extension sequences for diabodies

Anti-VLA-4 antibodies

TREATMENT WITH ANTI-VEGF ANTIBODIES

ANTI-CD38 HUMAN ANTIBODIES AND USES THEREFOR

Antibodies that bind colony stimulating factor 1 receptor (CSF1R)

Anti-CGRP compositions and use thereof

Anti-CGRP compositions and use thereof

Anti-CGRP compositions and use thereof

Anti-CGRP compositions and use thereof

Antibody binding agents that bind and uses thereof

Antibodies capable of specifically binding two epitopes on tissue factor pathway inhibitor

Anti-OX40 antibodies and diagnostic uses thereof

Antibodies against human CSF-1R and uses thereof

Anti-Laminin4 antibodies specific for LG4-5

IL33 form, mutated forms of IL33, antibodies, assays and methods of using the same

Humanized anti-CD79b antibodies and immunoconjugates and methods of use

Anti-transthyretin antibodies

Humanized antibodies that recognize alpha-synuclein

Binding molecules specific for CD73 and uses thereof

IL2Rbeta/common gamma chain antibodies

4-1BB binding molecules

Antagonistic anti-tumor necrosis factor receptor 2 antibodies

Anti-IL-17A antibodies and their use in treating autoimmune and inflammatory disorders

Conjugated biological molecules, pharmaceutical compositions and methods

Meditopes and meditope-binding antibodies and uses thereof

Carbonic anhydrase IX-specific antibodies and uses thereof

Antibody molecules to PD-L1 and methods of treating cancer

Anti-TIGIT antibodies and methods of use

Pyrrolobenzodiazepine antibody drug conjugates and methods of use

Transgenic plants expressing a variable domain of a heavy chain antibody (VHH) that binds to a sphingolipid of a fungus

Method for controlling affinity of antibody for antigen, antibody whose affinity for antigen has been altered, and its production method

Methods and compositions for treating fibrotic diseases

Monoclonal anti-alpha-synuclein antibodies for preventing tau aggregation

Compositions and methods for antibodies targeting BMP6

Anti-NTB-A antibodies and related compositions and methods

Antibodies against LIF and uses thereof

Compounds

ANTIBODIES AGAINST THE RGM A PROTEIN AND USES THEREOF

Methods for treating headache using antagonist antibodies directed against calcitonin gene-related peptide

POLYPEPTIDE MODIFICATION METHOD FOR PURIFYING POLYPEPTIDE MULTIMERS

METHODS OF TREATING TTP WITH IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS AND USES THEREOF

Methods of treating TTP with immunoglobulin single variable domains and uses thereof

Methods of treating TTP with immunoglobulin single variable domains and uses thereof

METHODS OF TREATING TTP WITH IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS AND USES THEREOF

Antigen binding molecules to TIGIT

Neutralizing anti-influenza binding molecules and uses thereof

Phage display library, members thereof and uses of the same

ANTI-GLYCOPROTEIN ANTIBODIES AND USES THEREOF

Antibodies to pyroglutamate amyloid-β and uses thereof

Humanized tau antibodies in a alzheimer's disease

Humanized antibodies

Monoclonal antigen-binding proteins to intracellular oncogene products

Anti-transferrin receptor antibodies and methods of use

Anti-vascular endothelial growth factor receptor 2 (VEGFR2) antibody and methods of use thereof for detecting VEGFR2 and for inhibiting tumor growth, tumor angiogenesis and/or inducing cancer cell cytotoxicity

Humanization of rabbit antibodies using a universal antibody framework

Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors

Immunoglobulins and uses thereof

Anti-IL-33 antibodies and uses thereof for disease treatment

Sensor systems for target ligands and uses thereof

Method for improving antibody

Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors

T CELL RETARGETING HETERO-DIMERIC IMMUNOGLOBULINS

Polynucleotides encoding anti-Notch1 NRR antibody polypeptides

HUMANIZED ANTIBODY OR FRAGMENT THEREOF SPECIFIC FOR CD3

Anti-PD1 antibodies and their use as therapeutics and diagnostics

Anti-c-Met antibody and anti-c-Met antibody-cytotoxic drug conjugate and pharmaceutical use thereof

ANTIBODIES AND IMMUNOCONJUGATES AND USES THEREFOR

Nucleic acids encoding bispecific antibodies binding to beta-Klotho and fibroblast growth factor receptor 1

Anti-MCAM antibodies and associated methods of use

Antibodies to amyloid beta

Monovalent, bivalent and trivalent anti human respiratory syncytial virus (HRSV) nanobody constructs for the prevention and/or treatment of respiratory tract infections

CHIMERIC ANTIGEN RECEPTOR T CELL SWITCHES AND USES THEREOF

HUMANIZED ANTI-FACTOR D ANTIBODIES AND USES THEREOF

Humanized Anti-CXCR5 Antibodies, Derivatives Thereof and Their Use

USE OF CAR-MODIFIED HUMAN NATURAL KILLER CELLS TO TREAT CANCER

POLYPEPTIDE COMPRISING AN IMMUNOGLOBULIN CHAIN VARIABLE DOMAIN WHICH BINDS TO CLOSTRIDIUM DIFFICILE TOXIN A

POLYPEPTIDE COMPRISING AN IMMUNOGLOBULIN CHAIN VARIABLE DOMAIN WHICH BINDS TO CLOSTRIDIUM DIFFICILE TOXIN B

Methods of treating vitiligo using PD-1 binding antibodies

High affinity antibodies that neutralize enterotoxin B